Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/1991
11/06/1991EP0455396A1 Aqueous gel compositions and their use
11/06/1991EP0454736A1 Fibrinolysis by il-4
11/06/1991EP0454726A1 Hindered linking agents and methods
11/05/1991US5063210 Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
11/05/1991US5063064 Lithium fluoride
11/05/1991CA1291748C .beta.-LACTAM ANTIBIOTICS
10/1991
10/31/1991WO1991016045A2 Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke
10/31/1991WO1991016042A1 Controlled release drug formulation
10/30/1991EP0454449A1 Carboxylic acid derivatives
10/30/1991EP0454044A2 Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
10/30/1991EP0453515A1 Composition for treatment of senile dementia
10/30/1991EP0453497A1 Treatment methods and vaccines
10/30/1991CN1055665A Use of anti-progestomimetic compounds in breeding animals
10/29/1991US5061710 Mercapto-acylamino acid antihypertensives
10/29/1991US5061694 Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
10/23/1991EP0453097A2 Zusammensetzung enthaltend zumindest zwei verschiedene Antikörper oder deren Fragmente
10/23/1991EP0453001A1 Pharmaceutical composition for the targeted controlled release of an active principle within the intestine, and particularly within the colon
10/23/1991EP0452315A1 Method of treating myeloid leukemias
10/22/1991US5059593 Pour-on formulations which are active against ticks
10/22/1991CA1291036C Nasal administration of drugs
10/18/1991CA2040471A1 Controlled release drug formulation
10/18/1991CA2035155A1 Pharmaceutical composition for the targeted controlled release of an active principle within the intestine, and particularly within the colon
10/17/1991WO1991015241A1 Percutaneously absorbable composition of narcotic and nonnarcotic analgesics
10/17/1991WO1991015233A1 Use of protease nexin-i to mediate wound healing
10/17/1991CA2079783A1 Use of protease nexin-i to mediate wound healing
10/16/1991EP0451880A2 An ex vivo tissue perfusion composition and the use thereof
10/13/1991WO1991016103A1 Improved iontophoretic administration of drugs
10/13/1991CA2080012A1 Iontophoretic administration of drugs
10/09/1991EP0451082A1 Ophthalmic product
10/09/1991EP0450757A2 Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood
10/09/1991EP0450095A1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor
10/09/1991EP0449968A1 PROCESS FOR THE PREPARATION OF HUMAN DNase
10/08/1991US5055447 Administering transforming growth factor beta
10/08/1991US5055228 Mixing with dispersion of spheres of lipid laminae
10/08/1991CA1290249C COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR
10/03/1991WO1991014455A1 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief
10/02/1991EP0449764A2 A method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptor antagonist
10/02/1991EP0449463A2 Method and composition for iontophoresis
10/02/1991EP0448895A1 Use of a non-alcoholic delivery system for active ingredients which are ingested orally
10/01/1991US5053419 Administering calcium channel antagonists
10/01/1991US5053388 Coating corneal incision with protein crosslinking compound, applying extra cellular matrix material, both with carriers
09/1991
09/27/1991WO1991014459A1 A bifunctional dtpa-type ligand
09/25/1991EP0448300A2 Method and composition for coiontophoresis
09/25/1991EP0448299A2 Composition for increased skin concentration of active agents by iontophoresis
09/25/1991EP0448274A2 Use of a thromboxane A2 receptor antagonist for the manufacture of a medicament for the treatment of ulcerative gastrointestinal conditions
09/25/1991EP0311616B1 Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases
09/24/1991US5051443 Wound healing agents for eyes a nonsteroid antiinflammatory agent
09/24/1991US5051435 Pharmaceutical preparations
09/24/1991US5051425 Therapeutic composition for combatting AIDS
09/24/1991US5051257 Antineoplastic solution and method for treating neoplasms
09/20/1991CA2037561A1 Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromboxane a2 receptor antagonist and combination useful in preventing and/or treatingulcers and/or inflammation
09/19/1991WO1991004058A3 Treatment of conditions and disease
09/18/1991EP0447298A1 Method for coating active agents with PH-sensitive polymers
09/18/1991EP0447297A1 Method for coating active agents with zein
09/18/1991EP0446753A1 Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films and their preparation process
09/18/1991EP0446298A1 Fast buccal tablet
09/17/1991WO1991013550A1 Synergistic compositions
09/17/1991US5049589 Antiviral aerosol compositions and pressurized containers containing same
09/17/1991US5049588 Novel treatment for ischemia using an aminotetralin
09/17/1991CA2076530A1 Synergistic compositions
09/14/1991WO1991013898A1 O6-benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing o6-alkylguanine-dna alkyltransferase depleting activity
09/11/1991EP0446124A2 Use of antiprogestomimetics to synchronise parturition in livestock
09/11/1991EP0445239A1 Anti-malarial composition and method of use
09/11/1991EP0445229A1 Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide
09/11/1991EP0445228A1 Immunotherapy involving cd28 stimulation
09/10/1991WO1991013870A1 Mercaptoacyl aminolactam endopeptidase inhibitors
09/10/1991WO1991013618A1 Phenyl butyl nitrone compositions for prevention of gastric ulceration
09/10/1991US5047435 Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections
09/10/1991US5047229 Treatment of cardiovascular and cerebral toxicity using calcium modulators
09/10/1991CA2077746A1 Mercaptoacyl aminolactam endopeptidase inhibitors
09/10/1991CA1288694C Process for treatment of diseases
09/10/1991CA1288688C Method for the diagnosis and treatment of inflammation
09/09/1991CA2037782A1 Process for zein coating of active ingredients
09/09/1991CA2037738A1 Active ingredient coating process using a ph-sensitive polymer
09/07/1991CA2037549A1 Anti-progestomimetic composition used in breeding animals
09/07/1991CA2036750A1 Method and composition for enhancing performance
09/05/1991WO1991012821A1 Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic
09/05/1991WO1991012813A1 Method for treating cancer using combination chemotherapy and brm
09/05/1991WO1991012806A1 Compositions and methods of treatment of sympathetically maintained pain
09/05/1991WO1991011201A3 Compounds
09/05/1991CA2408856A1 Pharmaceutical composition and use for limiting acute or chronic closure of a vascular lumen
09/04/1991EP0444181A1 C-erbb-2 external domain: gp75
09/04/1991EP0444157A1 Collagen-polymer conjugates
09/04/1991EP0444156A1 Method for treating vascular diseases
09/04/1991EP0293406B1 Solvent system for an ionizable pharmaceutical agent
09/03/1991WO1991013085A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis
09/03/1991WO1991012792A1 Method and product for promoting hair growth and treating skin conditions
09/03/1991US5045530 Conprising a micelle or a vesicle of a cationic teniside based on a hydrophobic alkyl-substituted pyridinium compound and a hydrophobic drug; drug delivery; skin disorders
09/03/1991US5045320 Large multivalent immunogen
09/03/1991US5044091 Frozen first and second liquid freeze dried together
09/03/1991CA2077345A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis
08/1991
08/23/1991CA2036774A1 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptorantagonist or a
08/21/1991EP0442141A1 Pharmaceutical preparation
08/20/1991US5041441 Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol
08/20/1991US5041430 Oral anticoagulant/platelet inhibitor low dose formulation
08/14/1991CA2036091A1 Pharmaceutical composition
08/13/1991US5039680 Administering methyl-imidazole substituted carbazolone
08/13/1991CA1287577C Growth promoting compositions
08/10/1991WO1991012003A1 Use of insulin sensitizing agents to treat hypertension
08/08/1991WO1991011201A2 Compounds